Track Microbot Medical Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Microbot Medical Inc. MBOT · Stock Open Microbot Medical Inc. in new tab

0.9787 USD
EPS
-0.25
P/B
1.08
ROE
-32.91
Beta
1.03
Target Price
5.38 USD
Loading chart...
Key Metrics
Earnings dateMarch 3, 2027
EPS-0.25
Book Value1.03
Price to Book1.08
Debt/Equity1.27
% Insiders0.014%
Estimates
Forward P/E-3.47
Forward EPS-0.32
Target Mean Price5.38

DCF valuation

Model fair value for Microbot Medical Inc. (MBOT)
Result
Sign in to run the valuation for MBOT.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
4 analysts · consensus Strong buy · mean target 5.38 USD (low 2.50, high 12.00) · as of 9 Nov 2026
Low 2.50
Mean 5.38
High 12.00
Price 0.9787
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Microbot Medical Inc. Logo Microbot Medical Inc. Analysis (MBOT)

United States Health Care Official Website Stock

Is Microbot Medical Inc. a good investment? Microbot Medical Inc. (MBOT) is currently trading at 0.9787 USD. Market analysts have a consensus price target of 5.38 USD. This suggests a potential upside from current levels.

Earnings Schedule: Microbot Medical Inc. is expected to release its next earnings report on March 3, 2027. The market consensus estimate for Forward EPS is -0.32.

Investor FAQ

Does Microbot Medical Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Microbot Medical Inc.?

Microbot Medical Inc. is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be March 3, 2027. The company currently has a trailing EPS of -0.25.

Company Profile

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Exchange Ticker
DUS (Germany) CY9D.DU
FRA (Germany) CY9D.F
STU (Germany) CY9D.SG
NMS (United States) MBOT
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
July 6, 2011 1:10
May 9, 2016 0.08
Nov. 29, 2016 0.11
Sept. 5, 2018 0.07
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion